Megace Tablets, 160 mg

Hazard statements (CLP)

H335, H341, H351

Code

Statements

H335

May cause respiratory irritation

SECTION 2: Hazards identification

Classification and Labelling Common to All Jurisdictions Classification Germ Cell Mutagenicity - Category 2 Carcinogenicity - Category 2 Toxic To Reproduction - Reproductive Toxicity - Category 1A Toxic To Reproduction - Developmental Toxicity - Category 1A Specific Target Organ Systemic Toxicity (Single Exposure) - Category 3 Specific Target Organ Systemic Toxicity (Repeated Exposure) - Category 1

Signal word

Danger

Hazard statements

Suspected of causing genetic defects. Suspected of causing cancer. May damage fertility (male reproductive toxicity, female reproductive toxicity) . May damage the unborn child (developmental toxicity) . May cause respiratory irritation . Causes damage to organs (male reproductive organs, female reproductive organs, adrenal glands, central nervous system, cardiovascular system) through prolonged or repeated exposure.

Precautionary statements

Do not breathe dust. Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Use personal protective equipment as required. Use only outdoors or in a well-ventilated area. Wash thoroughly after handling. Do not eat, drink or smoke when using this product.

2.1 Classification of the substance or mixture

Carcinogenicity - Category 2 Toxic To Reproduction - Reproductive Toxicity - Category 1A Toxic To Reproduction - Developmental Toxicity - Category 1A Specific Target Organ Systemic Toxicity (Single Exposure) - Category 3 Specific Target Organ Systemic Toxicity (Repeated Exposure) - Category 1 Symbol Signal Word Danger Hazard Suspected of causing genetic defects. Statements Suspected of causing cancer. May damage fertility (male reproductive toxicity, female reproductive toxicity) . May damage the unborn child (developmental toxicity) . May cause respiratory irritation . 2. HAZARDS IDENTIFICATION